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Introduction 
 
Public Relations (PR) has experienced various definitions, opinions, tools and functions over 
the past decades resulting in a conflicting perception of the term by both scholars and the 
public. Public Relations activities undertaken in the past have often been viewed by the media 
as a ‘PR scam’ and ‘just’ PR, etc. (1, p. 4), emphasising the negative connotation that the media 
portrays to the public. Nevertheless, if Public Relations is strategically practiced with the 
appropriate tools and ethical considerations, it can benefit both societies and corporations (2).  
 
The essence of Public Relations is of great importance, especially in complex sectors where 
communication is key to a better public outcome, such as the healthcare sector. Without the 
right communication tools, stakeholders might not be able to understand necessary information 
for their health and wellbeing. Unfortunately, the communication practice of the 
pharmaceutical industry has been strained by past scandals and its overall reputation and trust 
by the public has decreased (3). The combination of both the PR and pharmaceutical industry 
having a bad reputation complicates communication strategies further. Hence, the aim of this 
research is to investigate whether PR should be used in the pharmaceutical industry more, how 
PR can be used in the healthcare, as well as the impact of one PR campaign to patient’s 
wellbeing and engagement (i.e. Novartis ‘Living Like You’ campaign).  
 
Without a doubt, health is one of the most important areas of social activity. Just like in any 
other sector, PR is also needed in healthcare in order to communicate with its stakeholders and 
agree on mutual interests (4). According to Hetherington et al. (5), healthcare is a unique 
industry as it pulls a thin line between life, death and recovery. In addition, Willis (6) considers 
healthcare organisations to be encircled by ‘wicked’ problems, i.e. “those problems that are 
unstructured and difficult to define, cut across many stakeholders and are relentless” (p. 484). 
Healthcare as a sector has seen adjustments, as companies are now communicating directly to 
stakeholders, and as new innovations drive research and success (4). One of the key 
stakeholders for the healthcare industry is the patient group (PG) (7). Pharmaceutical 
companies often rely heavily on PGs as they seek to expand their market, to sell in their 
product, lobbying with governments, regulations or health service policies and lastly to be seen 
as a carrying and a socially responsible business (7).  
 
For PR professionals working within the healthcare field, the key challenge is communicating 
the same product to different audiences with different messages, i.e. a HCP will be introduced 
to a new product differently than a patient (8). Ideally, a strategic PR campaign, would execute 
both messaging streams in one campaign, preferably targeting special events to generate more 
media coverage. Experts believe that one of the key attributes of PR professionals working in 
the healthcare business is the act of listening to the patients rather than just transmitting the 
message (4). Therefore, using a Novartis case study, Living Like You (LLY), this paper intends 
to explore the ways PR is used in the pharmaceutical industry, by exploring the success of the 
LLY case.  
 
Living Like You 
 
Living Like You is a digital campaign sponsored by Novartis to empower and support patients 
impacted by multiple sclerosis (MS) to live fuller lives. The content displayed on the website, 
is from bloggers who are suffering from MS. Novartis wanted to showcase that they were not 
the ones writing the content but they were actually gathering the necessary resources for 
patients to really be able to find what they need; Novartis put the patients’ needs first. The 
topics that are addressed on the website range from “sex and parenthood to the benefits of 
handicapped parking badges, and new developments in the science around MS” (9; 10; 11). 
The page is focused on engaging patients and communicating with them on social media 
channels such as Facebook and Twitter. Novartis sponsors the content as they are committed 
to the MS community, but promise to have unbiased, useful and productive resources.  
 
In order to understand the campaign better, a general understanding of MS is needed. MS is a 
disease that affects the central nervous system, which includes the brain and spinal cord. These 
contain cells called neurons, designed to send signals throughout the body (12). These signals 
are responsible for many functions, including balance, physical coordination, eyesight, and 
memory (13). MS is mostly diagnosed between the ages of 20-50 and affects mostly female 
Caucasians (13). The cause of MS is unknown but due to the prevalence it is highly researched 
and treatment options are available by various pharmaceutical companies. Providing MS 
patients online access to relevant information is fundamental as people suffering from MS are 
up to three times more likely to be online compared to people with other diseases and as a result 
MS is mentioned online every 13 seconds (14). Due to these factors, an online campaign for 
MS patients is arguably a right choice.   
 
LLY has been awarded multiple times including the Sabre award in 2015 and the Clio Health 
award in 2016. With smaller campaigns like #MSLifeHacks, Novartis has called the attention 
of the media, patients and its competition (14). The question remains, why LLY is so different 
to other health awareness campaigns. Pharmaceutical companies are strictly regulated, both 
internally and by external bodies. The language that has been traditionally used is cold, clinical 
and lacks engagement and imposes fear. According to Dobrow (15, para. 4) patients have:  
 
“…Found similarly minded people on the Web and established communities in 
which the discussion, frankly, terrifies you. They talk about their feelings. They 
talk about self-made tweaks to official treatment regimens. They talk about sex 
(and do so employing language that might most accurately be described as “salty”). 
Most unsettlingly, they mock you pharmaceuticals and your efforts to educate 
them.” 
 
Novartis has been able to jump over various internal loops and was able to achieve an 
educational platform that also provides a sense of community for MS patients through content 
that is meaningful and needed by patients. As Stacey Bernstein from Weber Shandwick puts 
it, “Nobody's smarter about MS than a patient living with MS” (15). Healthcare communication 
campaigns are important in order to raise awareness of disease areas and treatment and to 
increase the reputation of pharmaceutical companies as whole. The paper aims to analyse LLY 
campaign and discuss the necessity of PR in relation to pharmaceutical companies.  
 
Method 
 
This paper used a qualitative research approach as it wanted to understand the use of public 
relations in the pharmaceutical sector, using Living Like You (LLY) as a case study to gain 
understanding into the subject.  LLY is an ideal case study for this paper as it is one of the only 
campaigns in recent pharmaceutical PR that has used the angle of positive communication to 
engage the audience and provide them with content that has the prospect to simplify and help 
their daily lives.  
 
Semi-structured interviews with public relations experts were conducted, explicitly in the field 
of pharmaceuticals to seek opinions and perspectives on public relations as a general 
profession, how to use PR in pharmaceutical sector and about importance of PR. Provided that 
this paper aims to explore reasons for needing PR and gaining common insights into the future 
of PR for the pharmaceutical industry, it is considered that 10 in-depth interviews will suffice 
in reaching the data saturation point (16; 17). The participants were all currently working in 
either a global agency working within the healthcare practice or at one of the top 20 
pharmaceutical companies worldwide (18). Each participant was considered an expert, if they 
had a minimum of five-year work experience in the field, yet the average was 13.5 years. The 
transcripts were analysed through unitising data, meaning that researcher reviewed all sets of 
data in order to fit them into the above-mentioned categories. Detailed quotes were used to 
justify the findings as well as tables showcasing yes and no answers to some of the questions 
asked.  
 
Findings  
 
The dataset is composed of 10 responses to the semi-structured interviews. 60% (6 
respondents) are working in one of the top 10 leading global agencies worldwide (19), 
specialising in the healthcare practice, while 30% of the participants (3 respondents) are 
working in the pharmaceutical industry and 10% (1 respondent) is working in the 
communication department of a patient advocacy group. 
 
The first question that was asked to the participants was to define public relations in their own 
words. Figure 1 showcases the word cloud, which clearly distinguished that the key words to 
defining public relations involved communicating, managing, stakeholders, external, and 
perception, all of which are very relevant, however engagement and digital were not rated high, 
which corresponds with current trends in the industry as explained above. 
 
Figure 1. Definition of PR using data visualisation 
 
 
When asking the respondents what they believe the public thinks of public relations and how 
they perceive it, the majority (70%) thought that the PR has a negative connotation in the 
public, whereas three participants (30%) believed that it depends on the situation. The 30% that 
did not have a clear answer believed that if you ask people who know and benefit from PR, 
they would think it is positive but people who lack knowledge of the term will most likely have 
a negative perception due to the influence of the media. In fact, 40% of the respondents said 
that the public had a negative perception of PR due to their lack of understanding of the term 
PR. In addition, 70% of all respondents believed that the public has a negative perception of 
PR because it is seen as: 
 
o “…Something trivial or something that manipulates or hides the truth.” (Participant 1)  
o “…Positioning things instead of saying things as they are.” (Participant 2) 
o “…Associate public relations with spin.” (Participant 3)  
o “…The general public…see it as spin…largely because what they see in films and TV, 
which is not showing reality.” (Participant 4) 
o “…Perception of being manipulated.” (Participant 6) 
o “…Sense that is very contrived, that people are controlling the messaging that is given 
to them…” (Participant 7)  
o “…Perceived as to cover up things.” (Participant 9) 
 
This is also in line with the research done by Keenan (20), Henderson (21), Bienkov (22), 
Coombs & Holladay (1) who believed that the media was also largely at fault for the 
misperception of PR within the public.  
 
When asking the participants whether PR is important for the healthcare system, i.e. not 
specifying on the pharmaceutical industry alone, 90% of the participants said yes and one 
participant said that it depended on the circumstances. The participants who said PR was 
important provided following reasons, which are showcased in the pie chart below, figure 2. 
The majority said education was the main reason why PR was important for the healthcare 
industry as it could educate people about diseases, treatment option and how to manage living 
with a disease. Without the right PR tools, the public would lack the knowledge and be 
overwhelmed with scientific jargon.  
 
Figure 2. Reasons for PR being important for the healthcare industry 
 
 
When asked whether PR could directly benefit the pharmaceutical industry, all participants 
strongly agreed, as participant 2 states, “The healthcare sector…is really under high scrutiny, 
so therefore PR is critically needed.” Also, participant 1 agrees that PR is key to improving the 
reputation, “It is really important for pharmaceutical companies to use PR as they have a huge 
image problem and I think it is important to manage that.” Nevertheless, participant 5 argues, 
“PR can help in changing the perception, but the behaviour of the industry is more important. 
PR won’t help if they won’t change their behaviour.” PR is a tool that can help companies 
communicate to the public and highlight the value and positive attributes it has. Nevertheless, 
at the end of the day actions say more than words and the pharmaceutical industry, as a whole, 
needs to change their behaviour.  
 
The expert interviews included questions on the influence of PR on patients. All agreed that a 
PR campaign could have a long lasting influence on patients. Two of the participants, provided 
the same example: the HIV campaign. In the 1980s, western countries launched a massive 
public health campaign to educate people of the consequences of HIV through scare tactics. 
Despite initial outrage, the campaign would later be known as the most successful. Participant 
6 remembers that living in the 1980s meant that you were fully aware of HIV/AIDS and were 
taken the precautions necessary not to contract the virus. However, the participant argues, that 
ever since the funding for public health campaigns in HIV/AIDS has decreased, a whole new 
generation is lacking awareness, most likely resulting in disease statistics increasing again. 
Participant 9 pointed out similar trends and mentioned that specifically in the UK, public health 
funding was decreased, which will also affect the healthcare system in the long run. In addition, 
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when asking participants whether they believed that a PR campaign could have a direct 
influence on the patients wellbeing the results where more varied as depicted in figure 3.  
 
Figure 3. Can PR influence patients' wellbeing 
 
   
 
 
Nevertheless, all participants mentioned that PR can influence patient’s wellbeing by providing 
accurate information, disease and treatment options. Participant 9 argues, that all of the 
information that is shared directly from pharmaceutical companies can be trusted as it is 
“heavily regulated and has to be accurate and balanced.” 
 
The question that concluded the most differences is whether pharmaceutical companies should 
invest more in PR. The results are shown in figure 4. There was a larger debate about this topic 
as trends showcase that not only PR is needed to bring the message across but rather a mix of 
tools, including advertisement and marketing. Nevertheless, some of the participants believed 
that PR was the more effective tool to work on the reputation of pharmaceutical companies 
(participant 7).  
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Figure 4. Should pharmaceutical companies invest more in PR? 
  
 
The key question that was asked during the expert interviews was whether PR was a necessity 
for the pharmaceutical industry. The results are showcased in figure 5 and highlight that the 
majority believe in the necessity.  
 
Figure 5. Does the pharmaceutical industry need PR? 
 
 
 
Participant 6, who argues that PR might not be a necessity points out that no matter what, 
patients will get sick and will likely turn to the pharmaceutical industry for medication, hence 
they will always have a mutual dependent relationship. Participant 7, argues that it depends on 
the circumstances, points out that depending what the goal of the pharmaceutical industry is 
they might need PR, for example if the goal is reputation then PR is needed. Participant 8, who 
works in a pharmaceutical company, argues that as soon as a company works with external 
stakeholders a PR strategy is needed. In addition, both participant 10 and 4 not only point out 
that PR is definitely needed in the pharmaceutical industry but rather that there should be much 
more of it, in order to improve their image and communicate the right messages to increase the 
wellbeing of the public. Participant 6 states,  
 
“Public relations is important to the pharmaceutical industry because we are trying to explain all the 
amasingly good stuff that pharmaceutical do but pharmaceutical can be their own worst enemy if things 
come to light about bad practices, because that is already what people are expecting to hear.”  
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In addition, participant 3 states that, “I don’t think it is just about PR and communications, it 
is the industry itself, it is being scrutinised and criticised, it has to also start to change and I 
think PR communications plays an important role.”   
Insights into Living Like You  
 
During the interview process, a specific section was dedicated to the case study, Living Like 
You (LLY). From all ten participants, nine (90%) of them were familiar with the campaign and 
were able to answer further questions set-forth. One of the participants had not heard of the 
campaign yet, hence the data moving forward only includes nine respondents. The participant 
that was unaware of the campaign, choose to explain a campaign that was significant to them, 
the Pfizer Viagra campaign. Nevertheless, all ten respondents were able to provide important 
insights into the case study, showcasing their expertise and the need for similar campaigns in 
the pharmaceutical industry.  
 
Historically, multiple sclerosis (MS) is a disease that affected older people; nevertheless in the 
last years MS has been diagnosed in younger people, especially women. According to 
participant 4, “…the treatment landscape of MS has evolved, the online landscape has not.” 
Furthermore, the interviewees pointed out that when people are diagnosed, the reality is that 
they will do research online, and this is also in line with the literature review that was 
conducted, showcasing that 44% of European online consumers use the internet to research 
health topics (23). Based on these statistics, it is crucial for pharmaceutical industries to use 
the online space to increase disease awareness, similar to what Novartis did. Understanding the 
landscape of the disease is fundamental, i.e. Novartis established that the online space was dry 
and static and not hopeful for newly diagnosed young patients. Patients with a chronic disease, 
such as MS do not only need information about treatment options, they need to know how they 
can continue living their lives, the essence of LLY. Participant 1 also argued that it is essential 
for a successful campaign to talk to its audience as “people rather than patients” something that 
Novartis took into consideration and reflected in LLY.   
 
When asking the participants, whether they consider LLY a PR campaign, different responses 
showcased the wide understanding and implication of PR. Participant 4, pointed out that it was 
more an “engagement campaign” whereas participant 9 and 3 said it was more of a “digital 
media campaign” or “PR and digital campaign.” A trend that can be analysed through the data 
set is the trend towards using words such as communication campaign or engagement 
campaign, rather than PR. The traditional use of the term PR is decreasing, which has also been 
argued with experts in the field. On the other hand, the act of communicating with stakeholders 
will always be necessary, specifically for the pharmaceutical sector.   
 
It is difficult to say whether the campaign has changed the lives of patients, but the positive 
comments and increased online engagement, showcase the potential of the campaign and the 
need for it. Also, some of the information provided online are difficult to find anywhere else 
and HCPs often cannot provide information, for example on medical marijuana or sex, making 
it a needed and useful campaign. Figure 6 shows the increase of median Facebook likes from 
the starting year (2014) until now (data collected 30.06.2016). 
 
 
 
Figure 6 Increase of Facebook Likes for Living Like You campaign 
 
 
Some of the positive comments that were found on social media can be found below, tackling 
sensitive topics such as sex (figure 8) and providing life hacks to improve day-to-day activities 
(figure 7).  
 
Figure 7. Facebook feedback on life hacks post (Living Like You, 2015a) 
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Figure 8 Facebook feedback on post about sex and MS (Living Like You, 2015b) 
 
 
Nevertheless, there are also some negative comments, an example can be found in below, figure 
9, which normally would have been ignored by pharmaceutical companies, but instead LLY 
answers the comments and provides insights and listens to the feedback the patients might 
have. The answers provided by LLY also show a personal, patient-centric approach as 
respondents are messaged directly with their first name and feedback is provided by both the 
users and LLY.  
 
Figure 9 Negative Facebook Comments (Living Like You, 2015c) 
 
 
Whether a similar campaign would work for other pharmaceutical companies depends on the 
disease area, nevertheless a patient centric approach is the future of disease awareness and 
communication. According to participant 4 it is important to,  
 
“…listen to what the real needs of the patients are and we are going to deliver against those needs and we are not 
going to just do what makes us feel comfortable but are going to do what is needed.”  
 
Participant 9 agrees and points out that, “we should be providing what patients want and not 
what we pharmaceutical companies think they want.” In order to break through in a crowded 
space, no matter the disease area, the campaign has to provide value, a unique platform that 
provides people content that they cannot find anywhere else and that they need to continue 
living their lives to the fullest. Pharmaceutical companies need to step out of their comfort zone 
and traditional PR executions, listen to the patient needs and develop campaigns targeted to 
their stakeholders needs rather than their own.  
 
Conclusion  
 
PR has and always will play a vital role in relationship building with stakeholders. It remains 
true, that corporations will have the most power and if they exercise this to benefit themselves, 
using PR tactics, it can be harmful for a stakeholder or society as a whole. Nevertheless, this is 
outweighed by the benefit that PR can have on society, especially in the healthcare sector. 
There is a need for PR to aid communication tactics in order for necessary health and wellbeing 
information to be shared with the public. It must be considered that without the pharmaceutical 
industry, the healthcare business would not be thriving like today and diseases that were active 
20 years ago possibly have a cure or treatment today. PR should remain to be a need for society, 
especially in the healthcare sector as it can be productive and addresses societal problems (24). 
It is crucial for the pharmaceutical sector’s reputation to communicate the good that they are 
doing for society and to explain to the public how their business is structured, by for example 
providing reasoning for their pricing structure.  
 
It can be concluded that the public has a negative view towards healthcare PR. The data that 
was collected throughout the semi-structured interviews revealed that 100% of the respondents 
agreed that the reputation of the pharmaceutical industry was negative. In addition, 70% of the 
respondents said that PR as a sector also had a negative connotation, which is line with the 
research done by Keenan (20), Henderson (21), Bienkov (22), Coombs & Holladay (1) who 
believed that the media was also largely at fault for the misperception of PR within the public. 
 
The case study Living Like You is a prime example how a PR campaign can have a positive 
influence on healthcare communication. The multi-awarded campaign showed positive and 
reactive responses towards consumers online. In addition, during the semi-structured 
interviews, 70% of the respondents agreed that PR could have a possible influence on a 
patient’s wellbeing. In addition, research and discussions with experts revealed that one of the 
most famous PR health campaigns remains to be the HIV/AIDS campaign from the 1980s, 
which used successful scare tactics to ensure safe sexual behaviour. With recent public health 
budget cuts and a lack of focus on the subject, experts are seeing that the rise of HIV is possible, 
partially due to the lack of awareness and communication. Living Like You can be considered 
to have accomplished a positive change towards the MS community. The content provided on 
the website and social media platforms are relevant, unique and patient-focused. When asking 
the interview respondents about the campaign, the majority believed that it had a positive 
impact with its community.  
 
Due to the fact that the pharmaceutical industry is a multi-layered landscape, where different 
and sometimes-competing players manage communication it can lead to a lack of coordination 
and ineffective communication, which further strains the sector’s reputation. Therefore, it 
should be advised to the pharmaceutical industry to ensure the following: 
 Ensure transparency and honesty; the pharmaceutical industry needs to be aware 
of the previous scandals that shadowed the sector and react by ensuring up-most 
honesty and transparency during their day-to-day communication 
 Patient centric approach; in the future, pharmaceutical industries should focus 
more on the patient’s needs and listen to what they need in order to provide 
value driven content  
 Sector wide collaboration; as a whole sector it could be advised that 
pharmaceutical companies come together to develop a communication strategy 
to ensure the overall increase in their reputation and communicate the value that 
they provide to society  
 Walk the talk; ensure that what is being said is also shown in the way that the 
company acts as a whole  
 Education; it is key for society, the sector and HCPs alike to be continuously 
educated on the newest treatment developments or general disease awareness 
 Push the limits; despite the regulatory and legal framework that binds the 
pharmaceutical industry, it is key to push boundaries, get creative and ensure 
that patient’s needs are in the forefront of the business. 
As participant 7 pointed out  
 
“It is about collaborating with patients, it is about showing investment in them and showing a real 
commitment in wanting to change things and helping them rather than just selling a particular drug.”  
 
Furthermore it can be argued, and participant 9 also mentioned this, that the term PR might be 
interchangeable with general communication. This might be true and should be further 
researched by scholars, but it can be concluded for this paper that the key to successful 
communication, similar to the Living Like You campaign is for companies to push boundaries, 
listen to the needs of patients and provide value driven content. Indeed, PR is just a tool, and a 
tool can be misused, but either way, PR remains to be a necessity to ensure a mutual 
relationship with stakeholders and to maintain a functioning and healthy society. The majority 
of interview respondents (80%) believed that PR remains to be a necessity in healthcare 
communication, especially in the pharmaceutical industry.   
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